Adjuvant Therapy for Stage 2/3 Colorectal Cancer
1 Views
administrator
06/22/23
John L. Marshall, MD; Bert H. O’Neil, MD; Marwan Fakih, MD; Gabriela Chiorean, MD; and Wells A. Messersmith, MD, FACP, assess the current role of adjuvant chemotherapy for patients with stage 2 colorectal cancer and discuss the duration of adjuvant oxaliplatin-based therapy for stage 3 colon cancer, based on data from the phase III IDEA study.
-
Category
Show more
Facebook Comments
No comments found